Heding L G
Diabetologia. 1975 Dec;11(6):541-8. doi: 10.1007/BF01222104.
A routing radioimmunoassay for human C-peptide in serum is described. Antibodies against human C-peptide were raised by immunizing guinea pigs with human b-component. Nine out of 12 animals produced useful antibodies within 6 months. Insulin antibodies coupled to Sepharose were used to bind human proinsulin and insulin in the serum and after centrifugation C-peptide was determined in the supernatant. The detection limit of the assay (calculated as 2 SD from zero) was about 0.003 pmole of C-peptide (in 100 mul). The main sources of error were: (1) Normal and diabetic sera devoid of C-peptide gave a displacement of 125I-Tyr-C-peptide varying from 0 to 0.16 nM (6 different antisera). Only one antiserum (M 1181) showed no displacement, and the values of C-peptide determined with this antiserum in normal and diabetic sera were lower than the values determined with another antiserum, which gave a value of 0.07 nM in the sera free of C-peptide. It is suggested that displacement found with most antisera is due to substances in serum that are not related to C-peptide or proinsulin. (2) Serial dilutions of pancreatic extracts and sera may yield dilution curves slightly different to those of the synthetic standard. Possible explanations are discussed. These sources of error can be eliminated or reduced by the proper selection of antisera. Fasting sera from 15 normals, 8 maturity-onset diabetics and 10 insulin-requiring diabetics showed the following concentrations of C-peptide: (M 1181) 0.35 +/- 0.09, 0.74 +/- 0.51 and 0.21 +/- 0.14 (nM, mean +/- SD). One hour after 1.75 g/kg oral glucose the values increased to 2.24 +/- 0.71, 2.34 +/- 0.24 nM.
本文描述了一种用于血清中人类C肽的放射免疫分析方法。通过用人b组分免疫豚鼠来制备抗人类C肽抗体。12只动物中有9只在6个月内产生了有用的抗体。将与琼脂糖偶联的胰岛素抗体用于结合血清中的人胰岛素原和胰岛素,离心后测定上清液中的C肽。该分析方法的检测限(以距零的2个标准差计算)约为0.003皮摩尔C肽(在100微升中)。主要误差来源如下:(1)不含C肽的正常和糖尿病血清使125I-酪氨酸-C肽的置换量在0至0.16纳摩尔之间变化(6种不同抗血清)。只有一种抗血清(M 1181)未显示置换,用该抗血清在正常和糖尿病血清中测定的C肽值低于用另一种抗血清测定的值,后者在不含C肽的血清中给出的值为0.07纳摩尔。提示大多数抗血清出现的置换是由于血清中与C肽或胰岛素原无关的物质所致。(2)胰腺提取物和血清的系列稀释可能产生与合成标准品略有不同的稀释曲线。对可能的解释进行了讨论。通过适当选择抗血清可以消除或减少这些误差来源。15名正常人、8名成年发病型糖尿病患者和10名需要胰岛素治疗的糖尿病患者的空腹血清显示出以下C肽浓度:(M 1181)0.35±0.09、0.74±0.51和0.21±0.14(纳摩尔,均值±标准差)。口服1.75克/千克葡萄糖1小时后,这些值分别增至2.24±0.71、2.34±0.24纳摩尔。